September is designated as “Blood Cancer Awareness Month”, with various global activities that highlight and increase awareness of blood cancers for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of blood cancers, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia”
by Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. González-Rodríguez, Ángel R. Payer, Esther González-García, Alejandro López-Soto and Segundo Gonzalez
Cancers 2021, 13(9), 2112; https://doi.org/10.3390/cancers13092112
Available online: https://www.mdpi.com/2072-6694/13/9/2112

“The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression”
by Almudena García-Ortiz, Yaiza Rodríguez-García, Jessica Encinas, Elena Maroto-Martín, Eva Castellano, Joaquín Teixidó and Joaquín Martínez-López
Cancers 2021, 13(2), 217; https://doi.org/10.3390/cancers13020217
Available online: https://www.mdpi.com/2072-6694/13/2/217

“Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study”
by Evangelos Terpos, Maria Gavriatopoulou, Despina Fotiou, Chara Giatra, Ioannis Asimakopoulos, Maria Dimou, Aimilia D. Sklirou, Ioannis Ntanasis-Stathopoulos, Ismini Darmani, Alexandros Briasoulis et al.
Cancers 2021, 13(17), 4480; https://doi.org/10.3390/cancers13174480
Available online: https://www.mdpi.com/2072-6694/13/17/4480

“Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma”
by Ichiro Hanamura
Cancers 2021, 13(2), 256; https://doi.org/10.3390/cancers13020256
Available online: https://www.mdpi.com/2072-6694/13/2/256

“Janus Kinases in Leukemia”
by Juuli Raivola, Teemu Haikarainen, Bobin George Abraham and Olli Silvennoinen
Cancers 2021, 13(4), 800; https://doi.org/10.3390/cancers13040800
Available online: https://www.mdpi.com/2072-6694/13/4/800

“The Role of Tumor-Associated Macrophages in Hematologic Malignancies”
by Emanuele Cencini, Alberto Fabbri, Anna Sicuranza, Alessandro Gozzetti and Monica Bocchia
Cancers 2021, 13(14), 3597; https://doi.org/10.3390/cancers13143597
Available online: https://www.mdpi.com/2072-6694/13/14/3597

“MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia”
by Katerina Katsaraki, Paraskevi Karousi, Pinelopi I. Artemaki, Andreas Scorilas, Vasiliki Pappa, Christos K. Kontos and Sotirios G. Papageorgiou
Cancers 2021, 13(4), 593; https://doi.org/10.3390/cancers13040593
Available online: https://www.mdpi.com/2072-6694/13/4/593

“Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment”
by Susanne Ghandili, Martin Schönlein, Marc Lütgehetmann, Julian Schulze zur Wiesch, Heiko Becher, Carsten Bokemeyer, Marianne Sinn, Katja C. Weisel and Lisa B. Leypoldt
Cancers 2021, 13(15), 3800; https://doi.org/10.3390/cancers13153800
Available online: https://www.mdpi.com/2072-6694/13/15/3800

“Stromal Cells Serve Drug Resistance for Multiple Myeloma via Mitochondrial Transfer: A Study on Primary Myeloma and Stromal Cells”
by Zsolt Matula, Gábor Mikala, Szilvia Lukácsi, János Matkó, Tamás Kovács, Éva Monostori, Ferenc Uher and István Vályi-Nagy
Cancers 2021, 13(14), 3461; https://doi.org/10.3390/cancers13143461
Available online: https://www.mdpi.com/2072-6694/13/14/3461

“FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review”
by Aleksandra Sochacka-Ćwikła, Marcin Mączyński and Andrzej Regiec
Cancers 2022, 14(1), 87; https://doi.org/10.3390/cancers14010087
Available online: https://www.mdpi.com/2072-6694/14/1/87

You are welcome to submit relevant papers to the journal Cancers. For any questions, feel free to contact us.

Cancers Editorial Office